Smoking, reward responsiveness, and response inhibition: tests of an incentive motivational model by Powell, Jane H. et al.
 
 
University of East London Institutional Repository: http://roar.uel.ac.uk  
 
This paper is made available online in accordance with publisher policies. Please 
scroll down to view the document itself. Please refer to the repository record for this 
item and our policy information available from the repository home page for further 
information. 
 
To see the final version of this paper please visit the publisher’s website. 
Access to the published version may require a subscription. 
 
Author(s): Powell, Jane; Dawkins, Lynne; Davis, Robert E. 
Article title: Smoking, Reward Responsiveness, and Response Inhibition: Tests of 
an Incentive Motivational Model 
Year of publication: 2002 
Citation: Powell, J. et al (2002) ‘Smoking, Reward Responsiveness, and Response 
Inhibition: Tests of an Incentive Motivational Model’ Biological Psychiatry 51 (2) 151-
163 
Link to published version: http://dx.doi.org/10.1016/S0006-3223(01)01208-2  
DOI: 10.1016/S0006-3223(01)01208-2 
 
 
Smoking, Reward Responsiveness, and 
Response Inhibition: Tests of an Incentive 
Motivational Model 
 
Jane Powell, Lynne Dawkins, and Robert E. Davis 
 
Background: Incentive–motivation models of addiction suggest impairment of functional activity in 
mesocorticolimbic reward pathways during abstinence. This study tested implications for subjective 
and behavioral responses to nondrug incentives, cue-elicited craving, and prefrontal cognitive 
functions, particularly response inhibition. 
 
Methods: We tested 26 smokers after smoking and after overnight abstinence in counterbalanced 
order; 26 nonsmokers were also tested twice. Measures included a simple card-sorting test performed 
with and without financial incentive (the CARROT), the Snaith Hamilton Pleasure Scale as an index of 
subjective reward responsiveness, ratings of subjective craving and withdrawal before and after 
exposure to a cigarette, an index of oculomotor response inhibition (saccadic vs. antisaccadic eye 
movements), verbal fluency, and reversed digit span. 
 
Results: Compared with the smoking condition, and independently of withdrawal severity, abstinence 
was associated with reduced cue reactivity, pleasure expectancies, responsiveness to financial 
incentive, and response inhibition (antisaccadic eye movements). Verbal fluency and reversed digit 
span were unaffected, contrary to findings elsewhere with heavier smokers. Nonsmokers’ scores either 
fell between those of abstainers and recent smokers or approximated those of recent smokers. 
 
Conclusions: The data were in general consistent with behavioral predictions derived from the 
incentive–motivational model of addiction and suggest that abstinence may be associated with 
impairments of motivation and response inhibition, which are independent of other subjectively 
experienced withdrawal symptoms.  
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Introduction 
 
It is now widely argued that compulsive drug use is more clearly driven by the achievement of 
pleasurable states than by the relief of aversive physical and/or emotional states (e.g., Stewart et al 
1984; reviews by Lyvers, 1998, and Robinson and Berridge, 1993). Consistent with this formulation, 
contemporary neurobiological models of addiction strongly implicate the mesocorticolimbic brain 
system comprising projections from the ventral tegmental area (VTA) to structures including the 
nucleus accumbens, amygdala, anterior cingulate, and prefrontal cortex. Functionally, this circuitry 
corresponds to the so-called reward pathways of the brain because its activation is associated with 
appetitive behaviors directed at obtaining a wide range of reinforcers including brain electostimulation, 
food, and sex (e.g., Wise, 1998). In relation specifically to smoking, Stein et al (1998), using functional 
magnetic resonance imaging (fMRI), found intravenous nicotine injections in smokers to induce 
subjective drug effects in parallel with elevated activity in the above-mentioned structures. The 
subjective correlate of the activation of reward pathways is, arguably, a state of heightened desire, 
wanting, or craving (e.g., Robinson and Berridge, 1993, 2000). Exposing addicts to drug-related 
stimuli elicits both subjective craving (e.g., Carter and Tiffany 1999) and activation of 
mesocorticolimbic structures (e.g., Childress et al 1999; Grant et al 1996; Volkow et al 1999).  
 
Activation of brain reward pathways by a single drug dose or exposure to drug-related stimuli may 
explain rapid reinstatement of addiction following a period of abstinence. Thus, for example, rats show 
reinstatement of previously extinguished nicotine seeking and consumption when given “priming” 
injections of nicotine (Shaham et al 1997). Such priming effects are, however, dose dependent: Markou 
et al. (1999) recently showed that preadministering rats cocaine doses below those self-administered 
during training increased instrumental responding for more cocaine, whereas priming doses similar to 
training doses reduced responding, possibly reflecting satiation. Effects depended also on whether the 
priming dose was “expected” by the animal (i.e., contingent vs. noncontin-gent) and on the type of 
behavioral paradigm used. Similar dose-dependent priming effects have been observed in relation to 
reinstatement of nicotine administration (Chiamulera et al 1996).  
 
In addition, small priming doses of one addictive drug have been shown to result in heightened 
subjective and behavioral reactions toward cues signalling the availability of a different drug (“cross 
sensitization”; see review by Self 1998). Nicotine shares the ability to cross-sensitize: in a double-blind 
placebo-controlled study with abstaining cocaine addicts, Reid et al (1998) found cue-elicited cocaine 
craving to be strongly enhanced by a dose of transdermal nicotine. Further evidence of associations 
between smoking, exposure to smoking-related cues, subjective craving, and neural activity in brain 
reward structures comes from a recent electroencephalographic study (Zinser et al 1999) showing 
heightened electrical activity in frontal cortex during both smoking and cue exposure. Interestingly, cue 
exposure, but not smoking itself, was associated with increased asymmetry of electrocortical activity, a 
putative physiologic marker of approach motivation. 
 
Smoking and Brain Reward Pathways: Implications for Cognitive Functioning 
 
The anterior cingulate (AC) and prefrontal cortex (PFC), cortical projection sites of the reward 
pathways, have been strongly associated with the executive cognitive functions involved in strategic 
problem solving and response planning (e.g., Jahanshahi and Frith 1998; Lezak 1995). In particular, 
PFC has been implicated in working memory (D’Esposito et al 1995; Goldman-Rakic 1995), response 
generation (Frith et al 1991), planning (e.g., Shallice and Burgess 1991) and suppression of reflex 
responses (e.g. Guitton et al 1985), whereas AC has been linked with executive attention (Posner and 
Petersen 1990), detection of erroneous responding (e.g., Dehaene et al 1994), oculomotor response 
inhibition (Gaymard et al 1996), and overcoming habitual responses (e.g., Crawford et al 1996).  
 
Theoretically, therefore, activation of reward pathways via either drug ingestion or perception of 
incentive stimuli is likely to modulate information-processing functions subserved by PFC and AC. 
This could be of biological value in facilitating the organization and execution of an effective plan of 
action directed at acquisition of the desired reinforcer. It might also be expected to have a general 
facilitative effect on executive functions that could be detected on a range of more abstract problem-
solving task. Interestingly, Ashby et al (1999) have recently reviewed evidence that activation of PFC 
via positive mood induction is associated with enhanced performance on a range of “frontal” tests. 
 
Until fairly recently, there was little convincing evidence that even chronic use of addictive drugs was 
associated with cognitive dysfunction, with few gross impairments seen in long-term cocaine or heroin 
users (e.g., Horner 1999; Selby and Azrin 1998). Evidence is accumulating for the existence of more 
subtle impairments, however, particularly of specific executive functions such as decision making and 
judgment (e.g., Bechara et al 2001; Grant et al 2000; Rogers et al 1999). These findings are 
complemented by neuroimaging studies showing abnormalities of the structure and function of frontal 
cortex in drug users (e.g., Liu et al 1998; London et al 2000). Different drugs may, however, produce 
subtly different effects depending on how they impact neurochemically on the pathways innervating 
different regions of PFC. For instance, Ornstein et al (2000) compared addicts whose primary drug was 
either heroin or amphetamine (although most also used a variety of other drugs) with matched non–
drug-using control subjects on a variety of neuropsychologic tests sensitive to fronto-striatal and 
temporal damage. Addicts showed selective and partially drug-specific patterns of impairment, with the 
heavy stimulant users showing more difficulty than the heavy opiate users on some fronto-striatal 
indices and the pattern reversing on others.  
 
Consistent with an impact of nicotine on executive functions, there is robust evidence that it enhances 
sustained, divided, and focused attention (Kassel 1997); conversely, abstinence has been associated 
with impaired working memory (e.g., Blake and Smith 1997). Conflicting results were reported by 
Park et al (2000): contrary to the authors’ predictions, recent nicotine consumption by smokers was 
associated with a decline in performance on a test of spatial working memory, selected specifically as a 
measure of dorsolateral PFC function. Spatial selective attention was unaffected. Although these 
findings await replication, they suggest that the effects of smoking and abstinence on cognitive 
functions are complex. This point emerges again from an experimental positron omission tomographic 
study (Ernst et al 2001), in which, although abstaining and ex-smokers scored equivalently on a test of 
working memory, their patterns of regional cerebral blood flow during the task differed, suggesting that 
abstinence did affect the information-processing strategies used on the task. 
 
Importantly, nicotine dependence, as with other addictions, has also been associated with poor 
inhibitory response control, a key function associated with PFC (e.g.. Hatsukami et al 1989). Addicts 
also show poor decision making on gambling tasks, tending to favour responses that produce short-
term gains but long-term losses (e.g., Grant et al 2000). Jentsch and Taylor (1999) suggested that this 
impulsive response style increases the risk of relapse. 
 
Effects of Smoking and Abstinence on Functioning of Brain Reward Circuitry in Chronic 
Smokers 
 
The preceding review suggests that activation of brain reward pathways may be associated with 
modulation of executive cognitive functions and with various aspects of incentive motivation. By 
implication, if addiction is indeed associated with abnormalities of reward mechanisms, then some or 
all of these functions might be compromised.  
 
Withdrawal from addictive drugs has been linked experimentally with reductions in incentive 
motivation. For instance, Epping-Jordan et al (1998) found that across four days of nicotine 
withdrawal, rats showed markedly increased thresholds for intracranial stimulation. Similar findings 
have been reported in relation to other addictive drugs (e.g., Kuhar and Pilotte, 1996; Wise and Munn 
1995), and Wise and Munn (1995) have suggested that dysfunction of brain reward pathways during 
withdrawal might underlie the characteristic subjective reports of anhedonia and dysphoria.  
 
There is growing evidence for addiction-related changes in the functional activity of dopamine (DA), 
the neurotransmitter that has been most strongly linked with functioning of the brain reward pathways 
(e.g., Fung and Lau 1988; Fung et al 1986). In smokers, for instance, Geracioti et al (1999) found 
abnormally low levels of a DA metabolite in cerebrospinal fluid. Reviewing an international 
symposium on this topic, Altmann et al (1996) concluded that “withdrawal from various drugs of abuse 
is associated with a reduction in dopamine transmission in the ventral striatum, an effect that is 
opposite to the common property of drugs of abuse to stimulate dopamine transmission.”  
 
Our study tests a number of predictions deriving from the above literature review concerning the 
effects of acute abstinence and smoking on cognitive and behavioural functions believed to be 
mediated by activity in brain reward pathways. Although not all of the predictions are unique to an 
incentive-motivational model of addiction, we are unaware of any other framework that would predict 
the same pattern of performance across the range of measures. 
 
1. APPETITIVE RESPONSES FOR NONDRUG INCENTIVES WILL BE IMPAIRED DURING ABSTINENCE.  
 
Evidence has been reviewed that response to incentives of most kinds is mediated by activity in brain 
pathways that nicotine and other addictive drugs appear to activate directly, that such drug-induced 
activation increases appetitive behaviors directed at further drug intake (priming and cross-priming), 
and that in animals acute abstinence is associated with elevated reward thresholds. If addiction indeed 
compromises mechanisms that mediate general incentive responses, then abstaining smokers should 
show reduced instrumental responding and subjective desire for a range of “normal” rewards compared 
with non-smokers. Furthermore, if nicotine consumption enhances functioning of these reward 
mechanisms, then their responses should be elevated after smoking. 
 
These predictions are investigated firstly using a behavioural measure of responsiveness to financial 
incentive, the Card Arranging Reward Responsivity Objective Test (CARROT; Powell et al 1996) in 
which participants sort cards under conditions of nonreward and reward. Reward responsiveness 
(acceleration in sorting rate under reward) has been found to correlate highly with measures of 
executive functioning and with clinical ratings of motivation during rehabilitation in patients with brain 
injury (Al-Adawi et al 1998); these indices all showed concomitant recovery during a period of 
treatment with bromocriptine, a dopamine agonist (Powell et al 1996). In a previous study with heavy 
smokers, reward responsiveness was impaired during abstinence and restored after a single cigarette 
(Al-Adawi and Powell 1997). Because nonrewarded sorting speed in these studies was unrelated to 
executive function and insensitive to drug manipulations, reward responsiveness effects cannot readily 
be interpreted as secondary to generalized psychomotor slowing. 
 
To complement this experimental behavioral measure of reward responsiveness, the self-report Snaith-
Hamilton Pleasure Scale (SHAPS; Snaith et al 1995) is used here to quantify respondents’ expectations 
of enjoying a range of naturalistic reinforcers (e.g., social events, a favourite meal). 
 
2. SMOKING-RELATED STIMULI WILL ELICIT GREATER INCREASES IN SUBJECTIVE CRAVING FOLLOWING 
SMOKING THAN DURING ACUTE ABSTINENCE AND WILL BE ASSOCIATED WITH DECREASES IN WITHDRAWAL 
SYMPTOMS.  
 
If the responses elicited by drugrelated stimuli reflect conditioned activation of brain reward pathways 
as indicated by Robinson and Berridge’s (1993) incentive–sensitization model of addiction, cue 
reactivity should be reduced during abstinence when these pathways are putatively relatively 
unreactive but enhanced immediately after drug consumption. Insofar as the conditioned response thus 
mimics direct drug effects, subjective withdrawal should tend to decrease during cue exposure. 
 
A competing argument is that abstinence might increasecue reactivity by inducing a deprivation state 
and thus enhancing the salience of cues of drug availability (e.g., Baker et al 1987; Stewart et al 1984). 
Whereas some studies have found no effect of abstinence on cue-elicited craving or physiological 
responses (e.g., Drobes and Tiffany 1997), in a study by Payne et al (1996) cue-elicited increases in 
craving were greater within 90 min of smoking than after 180 min of abstinence, despite the fact that 
preexposure craving was not at ceiling.  
 
Our present study employs a brief test of cue reactivity, measuring participants’ subjective craving and 
symptoms before and after they held and smelled a cigarette. Participants were permitted to smoke 
immediately after the test because drug availability has been shown elsewhere to enhance appetitive 
states and responses during cue exposure (e.g., Juliano and Brandon 1998; Powell, 1995). 
 
3. PERFORMANCE ON COGNITIVE TASKS TAPPING THE EXECUTIVE FUNCTIONS OF PREFRONTAL CORTEX, 
PARTICULARLY RESPONSE INHIBITION, SHOULD BE BETTER FOLLOWING SMOKING THAN DURING ACUTE 
ABSTINENCE.  
 
The clearest predictions for the effects of smoking and abstinence concern the inhibition of dominant or 
reflexive responses, a fundamental control function of PFC. Activation in various regions of PFC and 
AC tends to be associated with the execution of inhibitory responses on go/no-go tasks (e.g, Rubia et al 
2001). If, as empirical data indicate, drug dependence is associated with lowered levels of frontal 
functioning, then smokers should show reduced ability to inhibit automatic responses except shortly 
after smoking when the immediate enhancement of frontal activity by nicotine should restore inhibitory 
control. 
 
Our measure of response inhibition is an oculomotor task in which participants are required to inhibit 
reflexive eye movements (prosaccades or reflexive saccades) toward a peripheral stimulus and instead 
to make movements away from it (antisaccades). This task has previously been linked directly to 
activation of PFC and AC (e.g., Everling and Fischer 1998; Gaymard et al 1996; Guitton et al 1985); 
patients with frontal lesions are impaired on this task (e.g., Gooding et al 1997) and the probable 
involvement of executive cognitive processes is widely recognized (Findlay and Waler 1999; Gooding 
1999). The effects of nicotine on eye movements has been little studied, although smoking has been 
observed to decrease intrusive reflexive saccades during smooth pursuit tracking (Klein and Andresen 
1991; Olincy et al 1995). Here, we predict that abstinence will impair accuracy on the antisaccade but 
not on the reflexive saccade task. 
 
We also administered two other tests commonly used clinically to tap other aspects of executive 
function. Verbal fluency (Benton 1968) is often interpreted as a measure of strategic response 
generation or willed action (e.g., Jahanshahi and Frith 1998), whereas digit span (Wechsler 1981) taps 
working memory. Al-Adawi and Powell (1997) found both to be enhanced in smokers after smoking 
compared with during abstinence. 
 
 
 
 
 
 
Methods and Materials 
 
Design 
 
Twenty-six smokers were each tested twice, a week apart, once when they had been requested to 
abstain from smoking overnight and up to the time of the test session (at least 10 hours in total) and 
once just after smoking a cigarette; half were randomly allocated to the order abstinent/cigarette 
(Group AB/CIG) and half to the order cigarette/abstinent (Group CIG/AB). Twenty-six “never-
smokers” (Group NOSMOKE) were also tested twice to provide normative data against which to 
compare the absolute levels of performance of the smoking groups on each occasion separately. 
 
Exhaled CO levels were measured before each test session, and any smoker whose level in the just-
smoked condition fell within the range shown by the nonsmokers (0–5 parts per million [ppm]) or 
whose level in the abstinent condition was less than 4 ppm lower than their reading in the just-smoked 
condition was excluded. Five participants were excluded for one or both of these reasons, leaving 26 
(13 in AB/CIG and 13 in CIG/AB). 
 
Ethical Issues 
 
Our study was approved by Goldsmiths College Ethics Committee. All participants were volunteers 
recruited through advertisements on college noticeboards. They received no financial renumeration 
other than their earnings (less than £2) on the CARROT, although some undergraduates received 
course credits as part of an experimental participation course. “Oral and written explanations of the 
experimental protocol were given to participants, and their verbal informed consent was required 
before an appointment was made for their first experimental assessment. They were told that they could 
withdraw from the study at any time. All participants were independent adults capable of giving 
informed consent.” 
 
Assessment Measures 
 
The measures described below were administered in the following order: demographic and smoking 
information (time 1 only), reflexive saccade task, verbal fluency, antisaccade task, cue exposure, 
CARROT, and reversed digit span. 
 
Demographics and Smoking Related Variables 
 
The Fagerström Test of Nicotine Dependence (FTND; Heatherton et al 1991) is a six-item self-report 
scale concerning various indicators of dependence. Scores range from 0 (low dependence) to 10 (high 
dependence). Expired carbon monoxide was recorded before each session using a breath CO monitor. 
The half-life of CO is 2–5 hours, and therefore 10 hours of abstinence should be associated with 
markedly reduced CO levels. Here, no nonsmoker showed a difference exceeding 3 ppm between the 
two occasions, whereas for smokers the differences between abstinence and smoking conditions ranged 
from 4–22 ppm (M 11.5, ± 5.1). 
 
Responsiveness to Nondrug Incentives 
 
In the CARROT (Powell et al 1996), participants are given a stack of cards, each showing five digits of 
which one, and one only, is a 1, 2, or 3. The cards have to be sorted into corresponding numbered piles. 
In both testing sessions, there is first a baseline trial (T1) in which the participant is required to sort 
exactly 60 cards as quickly as possible. The time taken is then used as the individualized time limit in 
the subsequent three experimental trials (T2, T3, T4), for which a larger stack of cards is provided. In 
T3, the rewarded condition (REW), the participant is informed that s/he will receive 10 pence for every 
five cards sorted, and a 10 pence coin (15 cents) is placed on the table in full view after every fifth 
card. In T2 and T4, there is no reward, but the instruction is still to sort as rapidly as possible. 
Performance in these two trials is averaged to yield a nonreward (NONREW) index. Rate of sorting 
(cards per second) is computed for each individual trial, and a reward responsiveness index 
(REWRESP) is derived by subtracting the NONREW rate from the REW rate. 
 
The SHAPS (Snaith et al 1995) is a 14-item self-report scale designed to assess state dependent 
hedonic tone in healthy and psychiatric populations. Subjects indicate whether they agree that they 
would enjoy each of 14 normally pleasurable events or activities; each item is scored 0 (disagree) or 1 
(agree). 
 
Cue Reactivity 
 
Smokers, but not nonsmokers, rated their urge to smoke and withdrawal symptoms before and after 
being given a cigarette of their preferred brand to hold and smell. They were asked to take the cigarette 
out of a packet, sniff it, and then hold it in their hand while completing the ratings for the second time. 
Total exposure duration was approximately 2 min. 
 
Desire to smoke was assessed using a shortened version of the Questionnaire of Smoking Urges (QSU; 
Tiffany and Drobes 1991), a 32-item instrument comprising two factor-analytically derived subscales, 
A and B. For brevity, we used an abbreviated scale comprising those items loading higher than 0.55: 
six on A relating to immediate desire/urge/intention to smoke a cigarette and expected pleasantness of 
doing so, and three on B (beliefs that smoking will reduce depression and improve control and that 
“nothing would be better than a cigarette right now”). Items were rated between 1 and 7, and mean 
item scores were computed for the two subscales separately and for the combined scale. 
 
The severity of seven nicotine withdrawal symptoms (depression, irritability, anxiety, drowsiness, 
restlessness, hunger, poor concentration) were rated on 5-point scales (Hughes and Hatsukami 1986). 
 
Indices of Prefrontal Cognitive Function 
 
Response inhibition—antisaccadic oculomotor responding involves measuring the accuracy of 
prosaccadic and antisaccadic eye movements. Findlay and Walker (1999) described the antisaccadic 
task as involving “the voluntary inhibition of a reflexive saccade and the cognitive manipulation of the 
spatial parameters to produce a response in the opposite direction.” Participants were tested in a quiet, 
darkened room where they were seated in front of a 35-cm computer monitor and fitted with eye-
tracking headgear. A chin rest 25 cm from the screen minimized head movement. The equipment was 
calibrated for each participant before each task by asking them to look at a white dot subtending a 
visual angle of < 0.25 against a dark background at three positions (central fixation, +24° and -4°) for 5 
sec each. Horizontal eye movements were measured for the right eye only using an infrared reflection 
technique (IRIS IR 6500 by Skalar Medical, Delft, Netherlands) with a sampling rate of 120 Hz. 
Incoming eye-movement recordings were digitized using a Brain Boxes 12-bit analogue to digital 
conversion card. This in turn was connected to the data-logging IBM-compatible desktop computer. 
 
In the experimental task, a central fixation target was presented for a period varying randomly between 
2 and 4 sec; 200 msec after it was extinguished, one of six peripheral targets was illuminated for 500 
msec. The central fixation point was then reilluminated. Peripheral targets varied in both direction (left 
or right of the fixation point) and amplitude (i.e., 8°, 12°, or 24°) and were presented in a randomized 
order. We presented 60 peripheral stimuli, 10 in each of the six positions.  
 
This procedure was conducted first with prosaccades, when participants were instructed to look at the 
peripheral target as quickly and accurately as possible, and then, after a 5-min break, with antisaccades, 
when they were told instead to look in the opposite direction as quickly as possible and at 
approximately equal distance from the fixation point. Within each condition, responses were classified 
as incorrect if the initial movement was in the wrong direction regardless of whether it was 
subsequently corrected. Mean number of correct responses was calculated for each of the six stimulus 
positions. 
 
The Controlled Oral Word Association Test (Benton 1968) was used to measure verbal fluency. 
Participants were required to generate as many words as possible beginning with each of three letters 
excluding proper nouns or the same word with different suffixes. Equivalent letter combinations (FAS 
and DOT) were used for times 1 and 2, and the order of presentation was counter-balanced. Score is the 
total number of acceptable words over all three letters. 
 
Reversed Digit Span (e.g., Wechsler 1981) is a test of working memory in which participants listen to 
sequences of numbers that gradually increase in length and then repeat them in reverse order. Testing is 
terminated after two consecutive failures at the same sequence length. Equivalent number sequences 
were used for times 1 and 2, and the order of presentation was counter-balanced. One point is given for 
each sequence of numbers correctly reversed.  
 
Statistical Analysis 
 
All experimental variables were analyzed in two stages. First, the smoking groups (CIG/AB, AB/CIG) 
were compared with each other in a repeated measures analyses of variance (ANOVA) with the within-
subject factor of Time (first vs. second occasion of testing). In each case it is the Group _ Time 
interaction that is of theoretical interest because the CIG/AB group was tested first after smoking and 
second after abstaining, whereas the AB/CIG group was abstinent at time 1 and had smoked at time 2. 
If smoking status affects performance on the experimental measures in the predicted manner, then 
crossover interactions are predicted with CIG/AB subjects performing better at time 1 than at time 2 
and the AB/CIG group performing better at time 2 than time 1. Where significant interactions were 
found, the possible impact of withdrawal symptomatology was assessed by covarying out change-in-
withdrawal scores across the two test sessions. 
 
The second state of analysis investigated how the test scores of acutely abstinent and recent smokers 
compared with those of nonsmokers. This was achieved by comparing the two smoking groups with 
the nonsmoking group in one-way ANOVAs conducted separately at time 1 and time 2. A priori 
contrasts were specified to restrict the analysis of between-groups effects to these two comparisons 
(abstinent smokers vs. nonsmokers and recent smokers vs. nonsmokers). The main omnibus effect of 
group is not of direct interest and is therefore not reported; when contrasts are specified a priori, it is 
not necessary for the omnibus effect to be significant (e.g., Keppel 1991). Because the two contrasts 
are not orthogonal, however, Bonferroni corrections have been applied, adjusting the significance level 
to p < .025. This two-stage approach provided the most economic way of addressing the contrasts 
specified within the present hypotheses. 
 
Results 
Participants 
 
Descriptive statistics are shown in Table 1. The groups did not differ from one another in age or sex 
ratio. All smokers smoked more than 10 cigarettes a day and had done so for at least 1 year; the 
AB/CIG and CIG/AB groups did not differ significantly in this respect or in their Fagerström  nicotine 
dependence scores, which were low in both groups.  
 
For both smoking groups, the difference in CO levels between abstaining and smoking conditions was 
highly significant (CIG/AB: t12  = 9.6, p < .001; AB/CIG; t12 = 7.0, p < .001), and the two groups did 
not differ in this respect (t24  = 1.4, ns). By contrast, and as expected, the nonsmokers had lower CO 
levels than both smoking groups on both occasions, and showed no change in CO levels from the first 
to the second occasion of testing (t25 < 1.0, ns). 
 
Responsiveness to Nondrug Incentives 
 
CARROT REWARD RESPONSIVENESS. Table 2 shows sorting rates (cards per second) for the nonrewarded 
 
 
 
 
and rewarded trials separately, whereas Figure 1 gives a graphic representation of the derived reward 
responsivity variable (rate in rewarded minus rate in non-rewarded trials).  
 
Contrasting the AB/CIG and CIG/AB groups, there was a significant Group x Time x Reward 
interaction [F(1,24) = 7.5, p = .01] as predicted: both showed lower reward responsiveness (i.e., 
rewarded–nonrewarded rate) when abstinent than when they had just smoked. This effect remained 
significant when change in withdrawal symptoms was covaried out [F(1,23) = 6.3, p = .02]. 
 
There was no main effect of GROUP [F(1,24) < 1, ns], and none of the two-way interactions (Group x 
Reward, Group x Time, Reward x Time) reached significance [F(1,24) < 1.5, ns, in each case]. There 
was a main effect of Time [F(1,24) = 31.2, p = .001] with both groups sorting faster on the second 
occasion than the first, and the main effect of Reward was close to significance [F(1,24) = 4.0, p < .06) 
with sorting rate being elevated in the rewarded trial. 
 
To test the hypothesis that abstinent but not recent smokers would show lower reward responsiveness 
than nonsmokers, one-way ANOVAs were conducted at time 1 and time 2 separately with a priori 
contrasts to compare the scores of nonsmokers with those of the two smoking groups separately, as 
explained in the Analysis section above. The pattern was almost identical on the two occasions: recent 
smokers did not differ significantly from nonsmokers (t49  < 1, ns, both times), whereas abstaining 
smokers showed significantly lower reward responsiveness than nonsmokers at time 1 (t49 = -2.3, p < 
.025) and a trend in the same direction at time 2 (t49 = - 1.4, p = .08). 
 
 
 
SNAITH HAMILTON PLEASURE SCALE. One statistical outlier (>2 SDs from the mean) in the 
CIG/AB group was excluded from this analysis. Data for the remaining participants are summarized 
graphically in Figure 2.  
 
For the two smoking groups, there was a significant Group x Time crossover interaction [F(1,23) = 4.8, 
p < 0.05], with both groups showing elevated scores (indicative of low responsiveness to pleasurable 
stimuli) when abstinent and low scores (high responsiveness) after smoking. There was no main effect 
of either Group or Time [F(1,23) < 1.0, ns, for both). 
 
Neither of the smoking groups differed significantly from the nonsmokers at either time 1 or time 2 
(t49 < 1.5, ns, for every comparison). 
 
 
 
Figure 1. The Card Arranging Responsivity Objective Test reward responsiveness (increase in card-
sorting rate from nonreward to reward) for the three groups separately on the two assessment 
occasions. (cig) indicates score when tested just after smoking. (ab) indicates score when tested during 
abstinence. 
 
 
 
Figure 2. Snaith-Hamilton Pleasure Scale scores for the three groups separately on the two assessment 
occasions. High scores indicate low pleasure capacity. Data exclude one outlier from the 
cigarette/abstinent group. (cig) indicates score when tested just after smoking. (ab) indicates score 
when tested during abstinence. 
 
Cue Reactivity 
 
These data were not collected for nonsmokers, so the following analyses therefore compare the two 
smoking groups only. An additional within-subjects factor of Exposure (preexposure vs. postexposure 
ratings) was included in all analyses. Summary data for total QSU and withdrawal ratings are shown in 
Figures 3(a) and (b) respectively. 
 
 
QUESTIONNAIRE OF SMOKING URGES SCORES. For total QSU scores, there was, as 
expected, a significant main effect of EXPOSURE [F(1,24) = 5.4 p < .03], with average craving ratings 
increasing from before to after stimulus exposure. The Group x Time interaction was likewise 
significant [F(1,24) = 27.8, p < .001], with both groups reporting higher craving when abstinent. Most 
important, there was also a significant Group x Time x Exposure interaction [F(1,24) = 6.0, p < .025]. 
Inspection of Figure 3(a) shows that this reflected minimal alteration in craving following exposure to a 
cigarette for both groups when abstinent, contrasting with a much larger increase in the just-smoked 
condition. This three-way interaction remained significant when change-in-withdrawal symptoms 
across the two testing occasions was covaried [F(1,23) = 4.7, p < .05]. None of the other main effects 
or two-way interactions was significant. 
 
When the two subscales were analyzed separately, the pattern of results was very similar for both 
except that for Scale B the Group x Time x Exposure interaction, although of the same form as 
described above, fell short of statistical significance [F(1,24) = 2.1, p = .15]. 
 
 
WITHDRAWAL SYMPTOMS. As can be seen from Figure 3(b), there was a trend toward an overall 
reduction 
 
 
 
Figure 3. (A) Craving (total Questionnaire of Smoking Urges) ratings for the abstinent/cigarette and 
cigarette/abstinent groups separately, pre- and postexposure, on the two assessment occasions. (B) 
Withdrawal symptom ratings for the abstinent/cigarette and cigarette/abstinent groups separately, pre- 
and postexposure, on the two assessment occasions. (cig) indicates ratings when tested just after 
smoking. (ab) indicates ratings when tested 
during abstinence. 
 
 
 
in the level of self-reported withdrawal symptoms following exposure to a cigarette, although this fell 
short of significance [F(1,24) = 2.9, p = .10]. There were no significant interactions involving either 
Time or Group, although there was a weak trend for a Group x Time interaction [F(1,24) = 2.6, p = 
.12], which reflected slightly more elevated symptoms in the abstinent as opposed to the just-smoked 
condition for both groups. 
 
To explore further the relationship between cue-elicited craving and cue-elicited withdrawal symptoms, 
change (pre- to postexposure) scores were computed. During abstinence, the change scores correlated 
negatively although nonsignificantly (r26  = -.30, p = .14); after smoking, when subjective withdrawal 
symptoms were in any case very low, there was no hint of an association (r26 = -.04, ns). By contrast, 
prior to cigarette exposure, those participants who were abstaining showed a significant positive 
association between craving and withdrawal symptoms (r26 = .44, p < .03). 
 
 
 
Figure 4. Saccadic and antisaccadic eye movements: number correct, averaged across stimulus 
positions, for the three groups separately on the two assessment occasions. Participants with incomplete 
data and one outlier are excluded, leaving 22 in “never-smoker” group, 11 in the cigarette/abstinent 
group, and 12 in abstinent/cigarette group. (cig) indicates ratings when tested just after smoking. (ab) 
indicates ratings when tested during abstinence. 
 
 
Indices of Prefrontal Cognitive Function 
 
RESPONSE INHIBITION: SACCADIC AND ANTISACCADIC EYE MOVEMENTS. Data 
were incomplete for one participant in the AB/CIG group, one in the CIG/AB group, and four in the 
NOSMOKE group because of sudden movements or excessive blinking that disrupted calibration. One 
further CIG/AB participant was excluded because he was an extreme outlier on number of correct 
prosaccades on the second occasion (3.8 against an overall mean of 9.2 ± 0.6). The following analyses 
are thus based on 12 participants in AB/CIG, 11 in CIG/AB, and 23 in NOSMOKE; the number of 
correct responses for these participants are shown graphically in Figure 4.  
 
Tasktype (prosaccaadic vs. antisaccadic) was included as a within-subject factor. Data were averaged 
across the six stimulus positions; separate analyses, not reported here, confirmed that the pattern of 
results was almost identical when each position was considered individually.  
 
First comparing the two smoking groups within a repeated measures ANOVA, there were no main 
effects of Time or Group [F(1,21) < 1, ns], although there was a highly significant effect of 
TASKTYPE [F(1,21) = 80.2, p < .001], with many more errors being made in the antisaccadic than in 
the saccadic task. Both the Time x Group and Time x Group x Tasktype interactions were significant 
[F(1,21) = 21.9 and 15.5, p < .001], reflecting the fact that both groups made more errors on the 
antisaccadic task when they were abstinent; as can be seen from Figure 4, few errors were made on the 
saccadic task by any group on either occasion. When the ANOVA was repeated including change in 
withdrawal symptoms across the two occasions as a covariate, the critical three-way interaction 
remained highly significant [F(1,20) = 12.6, p < .005]. 
 
 
 
Comparing smokers with nonsmokers, inspection of Figure 4 shows that on the antisaccadic task 
nonsmokers scored somewhat better than abstaining smokers and somewhat worse than recent smokers 
on both occasions. These differences fell short of statistical significance, however (t42 < 1.8, ns, for all 
four contrasts). There was no indication of differences between smokers and nonsmokers on accuracy 
of prosaccades (t42 < 1.0, ns, in every contrast). 
 
VERBAL FLUENCY. These data are given in Table 3. Comparing the two smoking groups across the 
two occasions, there was an overall effect of Time [F(1,24) = 4.6, p < .05), with both groups 
generating more words on the second occasion than on the first. Although the data show a tendency for 
the improvement to be more pronounced in the ABCIG group as predicted, this Group x Time 
interaction fell well short of significance [F(1,24) = 1.05,ns]. 
 
At neither time 1 nor time 2 did either of the smoking groups differ from the nonsmokers (t49 < 1.5, ns, 
in every case). 
 
REVERSED DIGIT SPAN. Scores are shown in Table 3. Comparing the two smoking groups, there 
was no significant Group x Time interaction, nor main effects of either Time or Group [F(1,24) < 1, ns, 
in every case]. At neither time 1 nor time 2 did either of the smoking groups differ from the 
nonsmokers (t49 < 1.25, ns, in every case). 
 
Discussion 
 
Despite a compelling literature linking the addictive properties of nicotine to activity within distributed 
brain reward pathways, to date there has been little systematic exploration of the behavioral, cognitive, 
and subjective implications of the involvement of this neurobiological system in human smokers. Our 
study therefore tested a set of related hypotheses arising from an integration of existing data concerning 
the effects of addiction and abstinence. Specifically, it was predicted that during acute abstinence, 
smokers would show weakened incentive motivation and deficits on tests of prefrontal executive 
functions, especially response inhibition (Jentsch and Taylor 1999), reflecting low levels of activity in 
mesocorticolimbic pathways. 
 
The predictions concerning incentive motivation received strong support. Thus, on a simple card- 
sorting task (the CARROT), smokers who had recently smoked showed responsiveness to financial 
incentive that was equivalent to that of nonsmokers; by contrast, abstinence was associated with 
significantly lower reward responsiveness. Most important, in the absence of financial incentive all 
groups (abstinent smokers, recent smokers, and nonsmokers) sorted at similar rates. Impaired reward 
responsiveness during abstinence therefore cannot reflect either a generalized reduction in psychomotor 
speed or the operation of a ceiling effect. 
 
The above pattern was paralleled by changes in smokers’ subjective expectations of enjoying a range of 
normally pleasurable events; thus, on the SHAPS (Snaith et al 1995), abstaining smokers rated 
themselves as expecting significantly lower pleasure than did those who had just smoked. Again, 
abstaining smokers (but not recent smokers) showed reduced expectancies relative to nonsmokers; this 
effect was significant on one testing occasion and showed a nonsignificant trend in the same direction 
on the other. Both the reward responsiveness and the SHAPS effects remained significant when we 
controlled for subjectively rated withdrawal symptoms, suggesting that they are not simply secondary 
to the general malaise associated with acute abstinence. Further evidence for a dissocation between 
withdrawal symptoms and functional activity of brain reward pathways comes from a preclinical study 
by Carboni et al (2000) in which naloxone-precipitated withdrawal symptoms were not associated with 
alteration of central transmission of dopamine, the neurotransmitter most closely associated with 
reward processes (e.g., Fung et al 1986). 
 
On the test of cue reactivity, abstaining smokers showed virtually no increase in subjective craving 
following exposure to the sight, smell, and handling of a cigarette, whereas when tested just after 
smoking, they showed a pronounced increase. However, preexposure craving was markedly higher in 
the abstaining than in the smoking condition, albeit not at the ceiling of the scale. The observed 
interaction may therefore reflect to some extent the more restricted range for further increases in 
craving during abstinence. It is methodologically difficult if not impossible to eliminate this problem, 
and the observed pattern therefore remains ambiguous; however, there is clearly no support here for the 
alternative view that abstinence actually heightens cue reactivity by enhancing cue salience. The 
present findings are consistent with other reports that prior nicotine administration sensitizes subjective 
responses to cocaine-related cues (e.g., Reid et al 1998) and that heroin addicts show greater relative 
activation of prefrontal cortex and amygdala during exposure to heroin-related cues immediately 
following administration (under double-blind conditions) of an intravenous dose of heroin rather than 
placebo (Sell et al 1999). 
 
Interestingly, cue-elicited craving was not predicted by the severity of preexposure subjective 
withdrawal symptoms. This is incompatible with models asserting that the incentive salience of drug-
related cues is enhanced by withdrawal symptoms (e.g., Baker et al 1987, Stewart et al 1984) or which 
view craving primarily as a subjective correlate of withdrawal-like symptoms (e.g., Siegel 1979; 
Wikler 1965). Indeed, during cue exposure there was a trend for self-reported withdrawal symptoms to 
decrease, contrasting with the simultaneous increase in craving. In abstaining smokers, cue-elicited 
craving correlated negatively with cue-elicited withdrawal (r26= -.30), although this association fell 
just short of statistical significance. Thus, far from being associated with exacerbation of withdrawal, 
cue-elicited craving was weakly associated with improvements in physical state as would be expected 
if it is an appetitive rather than a withdrawal-related response. These findings have some interesting 
parallels in an experimental study of methadone consumption in which five opiate-dependent patients 
consumed more methadone if they had previously either smoked ad libitum or chewed 4 mg of nicotine 
gum than if they were nicotine-abstinent, despite reporting higher levels of nicotine craving and 
appetite in the abstinent condition (Spiga et al 1998). 
 
The present results therefore add to the evidence that craving has at least two facets that respectively 
relate to severity of subjective withdrawal symptoms and to the strength of a more positive, appetitive, 
state. Consistent with the predictions of the incentive–motivation model, appetitive effects appear more 
likely than withdrawal-like effects to be elicited by exposure to drug-related cues and to be depressed 
during abstinence. The two subscales of the QSU (Tiffany and Drobes 1991) were not sensitive to this 
possible dissociation, both following the same pattern in the present study; however, inspection of the 
item content of the abbreviated versions of the scales used here suggests that both include items that 
could be construed as appetitive and neither include items that are unambiguously related to relief of 
withdrawal symptoms. 
 
Turning finally to prefrontal cognitive functions, it was hypothesized that abstinence would be 
associated with impairments in inhibition of dominant responses (tested here using an oculomotor 
task), working memory (reversed digit span), and response generation (verbal fluency) and that 
smoking a cigarette would restore normal function. The prediction concerning the effect of smoking on 
response inhibition was strongly supported: not only was the mean accuracy of antisaccades strikingly 
lower during abstinence than after smoking, but of the 24 smokers for whom complete data were 
available, this pattern was shown by all but five. 
 
In contrast to the effect of smoking status on antisaccadic responses, it did not affect accuracy of 
prosaccadic responding, which was close to ceiling on both occasions. This overall pattern is consistent 
with the idea that smoking specifically increases the ability to inhibit the reflexive (dominant) response 
and that abstinence is associated with a reduction in the efficiency of inhibitory processes rather than in 
the ability to initiate or make oculomotor responses per se. As with the other measures, the effect 
remained strong after changes in withdrawal symptoms across the two testing sessions were taken into 
account, suggesting that the observed enhancement after smoking is not attributable to alleviation of 
general malaise. 
 
Interestingly, however, there was no support for the prediction that abstainers would be impaired 
relative to nonsmokers. In fact, although nonsmokers were marginally but nonsignificantly more 
accurate than abstaining smokers, they were slightly (although again nonsignificantly) outperformed by 
smokers who had just had a cigarette, especially on the first testing occasion. Although there were no 
obvious demographic differences between the groups, it is possible that some unmeasured difference 
between the smokers and nonsmokers could account for the nonsmokers’ failure to outperform 
abstaining smokers on the antisaccadic task; however, the trends in these data may also suggest that 
smoking can enhance response inhibition directly rather than simply by reversing a dependence-related 
deficit. Consistent with such an interpretation, a recent review of the complex empirical literature on 
neurochemical modulation of frontal-executive functions (Robbins 2000) concluded that drugs that 
enhance activity in pathways projecting to different regions of frontal cortex can have direct but mixed 
and dosedependent effects on executive cognitive tasks, varying as a function of the specific circuitry 
affected by the drug and involved in the task and on individual differences in baseline levels of 
performance. Thus, in some cases, dopamine agonists may enhance performance on executive tasks in 
people who perform them relatively poorly beforehand while having no effects in those who initially 
score highly (e.g., Kimberg et al 1997). Neuroimaging techniques have verified the activation of frontal 
cortexfollowing administration of dopamine agonists such as bromocriptine (e.g., Kimberg et al 2001). 
Such findings are particularly salient here because there is now an extensive literature demonstrating 
the close involvement of dopamine both in the functioning of brain reward circuitry and in the 
associated behavioral phenomena of addiction such as priming, incentive–sensitization, and cue 
reactivity (e.g., Robinson and Berridge 2000). Furthermore, there is clear evidence that nicotine 
consumption triggers, among other biochemical effects, release of dopamine in the shell of nucleus 
accumbens (Gamberino and Gold 1999), one of the structures at the heart of the reward circuitry 
projecting to frontal cortex. Thus, it is biologically as well as conceptually plausible that ingestion of 
nicotine by smoking could simultaneously modulate responses to incentive and enhance performance 
of executive tasks. 
 
The data reported here extend and substantially replicate our earlier finding (Al-Adawi and Powell 
1996) of reduced reward responsiveness in abstaining smokers; however, the previous study also 
showed significant effects of abstinence on verbal fluency and digit span, effects that did not emerge 
here. This may reflect the much higher level of dependence of Al-Adawi and Powell’s participants; in 
addition to smoking more cigarettes per day, their mean score on the Fagerström test of nicotine 
dependence (Heatherton et al 1991) was 7.9 ± 1.8, contrasting with 3.7 ± 2.2 here. It may be that the 
antisaccadic task is more sensitive than the other two indices of frontal function to relatively subtle 
aspects of executive cognitive functioning, and it would be of interest to assess a group of more heavily 
dependent smokers on this and other tests used in the present study to see whether they indeed 
demonstrate more pronounced impairments relative to nonsmokers on the various measures used here. 
 
The significant effects seen here for reward responsiveness and antisaccadic responses were small in 
absolute terms, and their functional significance is by no means clear. Nonetheless, a small effect of 
financial incentive on the intrinsically meaningless card-sorting task used here (compared with 
virtually no effect in abstaining smokers) could in principle predict willingness to put effort into 
significant work-related, domestic, or social activities; indeed, such a relationship was observed in our 
study with brain-injured patients (Powell et al 1996). Jentsch and Taylor (1999) suggested that 
impairments of response inhibition might be particularly important because of their potential for 
increasing the risk of impulsive drug use and thus of relapse. As far as we are aware, our study 
represents the first focused investigation of response inhibition per se in human drug users, and, 
although it does not show response inhibition to be worse in abstainers than in nonsmokers, it does 
confirm that smokers find it more difficult to inhibit responses when they are abstinent than when they 
are smoking. We are currently planning a prospective study that will investigate directly whether 
impairments of either reward responsiveness or response inhibition seen during acute nicotine 
abstinence predict either relapse or other aspects of social functioning. 
 
The dissociation between subjective withdrawal symptoms and the observed effects of smoking and 
abstinence on incentive motivation and cognitive functioning is of both theoretical interest and 
potential clinical importance. A reduction in the capacity to enjoy alternative sources of reward may 
undermine attempts at abstinence and thus contribute to relapse. Treatment with dopamine-enhancing 
drugs during this phase might counteract this effect, but, paradoxically, simultaneously increase 
reactivity to smoking- related cues. This would suggest that a combined pharmacologic and 
psychologic approach, which explicitly identifies the possible dual effects of drug treatment and which 
helps abstaining smokers to develop strategies for avoiding or coping with cue-elicited craving, might 
be the optimal way forward. 
 
Finally, our study does not illuminate either the aetiology or the time course of the observed deficits 
during smoking abstinence. They may have preceded onset of smoking or have developed during 
chronic smoking; they might be reversible, and they might not. If they are reversible, the time course of 
recovery is as yet unexplored. These represent important issues for future research as they would 
inform the provision of appropriate treatment and advice and might also provide a basis for predicting 
individual differences in liability to addiction or relapse.  
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